Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Philippe Gautret and Van Hoang.
Philippe Gautret
Connection Strength
8.062
Van Hoang
  1. Tokyo olympics, Hajj pilgrimage, Grand Magal of Touba and COVID-19. Travel Med Infect Dis. 2021 Jul-Aug; 42:102088.
    View in: PubMed
    Score: 0.948
  2. The Tokyo Olympic Games and the Risk of COVID-19. Curr Trop Med Rep. 2020; 7(4):126-132.
    View in: PubMed
    Score: 0.911
  3. COVID 19: Will the 2020 Hajj pilgrimage and Tokyo Olympic Games be cancelled? Travel Med Infect Dis. 2020 Mar - Apr; 34:101622.
    View in: PubMed
    Score: 0.871
  4. Does SARS-CoV-2 re-infection depend on virus variant? Clin Microbiol Infect. 2021 09; 27(9):1374-1375.
    View in: PubMed
    Score: 0.238
  5. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med. 2021 Jun 15; 10(12).
    View in: PubMed
    Score: 0.238
  6. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e1-1516.e6.
    View in: PubMed
    Score: 0.237
  7. Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann. Int J Antimicrob Agents. 2021 Mar; 57(3):106306.
    View in: PubMed
    Score: 0.232
  8. Variations in respiratory pathogen carriage among a homeless population in a shelter for men in Marseille, France, March-July 2020: cross-sectional 1-day surveys. Eur J Clin Microbiol Infect Dis. 2021 Jul; 40(7):1579-1582.
    View in: PubMed
    Score: 0.232
  9. Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020. Int J Infect Dis. 2021 Apr; 105:1-6.
    View in: PubMed
    Score: 0.232
  10. The Grand Magal of Touba was spared by the COVID-19 pandemic. Int J Infect Dis. 2021 Apr; 105:470-471.
    View in: PubMed
    Score: 0.231
  11. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021 Jun; 27(6):931-932.
    View in: PubMed
    Score: 0.231
  12. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Int J Antimicrob Agents. 2021 Jan; 57(1):106243.
    View in: PubMed
    Score: 0.230
  13. Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. Int J Antimicrob Agents. 2021 01; 57(1):106244.
    View in: PubMed
    Score: 0.230
  14. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. Int J Antimicrob Agents. 2021 01; 57(1):106237.
    View in: PubMed
    Score: 0.230
  15. Response to advances statistical methods and designs for clinical trials for COVID-19. Int J Antimicrob Agents. 2021 01; 57(1):106235.
    View in: PubMed
    Score: 0.230
  16. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. Int J Antimicrob Agents. 2021 Jan; 57(1):106239.
    View in: PubMed
    Score: 0.230
  17. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Int J Antimicrob Agents. 2021 01; 57(1):106241.
    View in: PubMed
    Score: 0.230
  18. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106242.
    View in: PubMed
    Score: 0.230
  19. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. Eur J Clin Microbiol Infect Dis. 2021 Jan; 40(1):13-25.
    View in: PubMed
    Score: 0.228
  20. The 2020 Grand Magal of Touba, Senegal in the time of the COVID-19 pandemic. Travel Med Infect Dis. 2020 Nov - Dec; 38:101880.
    View in: PubMed
    Score: 0.226
  21. Epidemiology of human common coronavirus acquisition in pilgrims. Travel Med Infect Dis. 2020 Sep - Oct; 37:101845.
    View in: PubMed
    Score: 0.224
  22. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.219
  23. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.218
  24. Refractory giardiasis in medical students returning from humanitarian work abroad. Travel Med Infect Dis. 2020 Jul - Aug; 36:101469.
    View in: PubMed
    Score: 0.210
  25. Preliminary Feasibility Study of Questionnaire-based Active Pulmonary Tuberculosis Screening in Marseille Sheltered Homeless People, Winter 2018. J Epidemiol Glob Health. 2019 06; 9(2):143-145.
    View in: PubMed
    Score: 0.206
  26. Low prevalence of resistance genes in sheltered homeless population in Marseille, France, 2014-2018. Infect Drug Resist. 2019; 12:1139-1151.
    View in: PubMed
    Score: 0.205
  27. Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881.
    View in: PubMed
    Score: 0.057
  28. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020 Jun; 39(6):1059-1061.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.